Bank of Montreal’s Clovis Oncology, Inc. CLVS Stock Holding History

Bank of Montreal’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-111,750	Closed	-$136	–	4514
2022 Q3	$136	Sell	111,750 -121,634	-52%	-$190K	﹤0.01%	3359
2022 Q2	$399	Buy	233,384 +205,048	+724%	+$302K	﹤0.01%	2832
2022 Q1	$48K	Buy	+28,336	New	+$55.7K	﹤0.01%	3804
2021 Q3	–	Sell	-4,793	Closed	-$30K	–	4012
2021 Q2	$30K	Sell	4,793 -2,343	-33%	-$13.7K	﹤0.01%	3475
2021 Q1	$47K	Sell	7,136 -52,261	-88%	-$350K	﹤0.01%	3735
2020 Q4	$334K	Sell	59,397 -18,407	-24%	-$93.1K	﹤0.01%	2933
2020 Q3	$438K	Sell	77,804 -79,045	-50%	-$473K	﹤0.01%	2383
2020 Q2	$1.05M	Buy	156,849 +80,293	+105%	+$608K	﹤0.01%	1899
2020 Q1	$465K	Sell	76,556 -16,721	-18%	-$134K	﹤0.01%	2013
2019 Q4	$973K	Sell	93,277 -12,572	-12%	-$91.4K	﹤0.01%	2291
2019 Q3	$416K	Buy	105,849 +96,197	+997%	+$778K	﹤0.01%	2510
2019 Q2	$143K	Buy	9,652 +3,457	+56%	+$62.5K	﹤0.01%	3119
2019 Q1	$153K	Sell	6,195 -1,243	-17%	-$31.2K	﹤0.01%	2865
2018 Q4	$134K	Sell	7,438 -28,607	-79%	-$585K	﹤0.01%	2797
2018 Q3	$1.06M	Buy	36,045 +20,214	+128%	+$783K	﹤0.01%	1975
2018 Q2	$720K	Buy	15,831 +15,203	+2,421%	+$739K	﹤0.01%	2168
2018 Q1	$34K	Sell	628 -4,455	-88%	-$260K	﹤0.01%	3388
2017 Q4	$346K	Sell	5,083 -1,000	-16%	-$69.9K	﹤0.01%	2449
2017 Q3	$501K	Buy	6,083 +3,381	+125%	+$268K	﹤0.01%	2274
2017 Q2	$253K	Buy	2,702 +2,000	+285%	+$122K	﹤0.01%	2551
2017 Q1	$45K	Sell	702 -11,800	-94%	-$717K	﹤0.01%	3126
2016 Q4	$428K	Buy	12,502 +3,339	+36%	+$118K	﹤0.01%	2182
2016 Q3	$330K	Buy	9,163 +6,000	+190%	+$129K	﹤0.01%	2243
2016 Q2	$43K	Sell	3,163 -132	-4%	-$1.93K	﹤0.01%	3112
2016 Q1	$64K	Sell	3,295 -4,202	-56%	-$88.9K	﹤0.01%	2960
2015 Q4	$263K	Buy	7,497 +6,042	+415%	+$390K	﹤0.01%	2266
2015 Q3	$134K	Buy	+1,455	New	+$126K	﹤0.01%	2462
2015 Q2	–	Sell	-445	Closed	-$33K	–	4168
2015 Q1	$33K	Buy	+445	New	+$31.4K	﹤0.01%	3087
2014 Q3	–	Sell	-450	Closed	-$19K	–	4516
2014 Q2	$19K	Buy	+450	New	+$23.2K	﹤0.01%	3617

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bank of Montreal's CLVS Position: Q4 2022 in Review

Bank of Montreal sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 111,750 shares — an estimated $136 sold.

Bank of Montreal first reported a position in CLVS in Q2 2014 and held it in 29 quarters. The position peaked at $1.06M in Q3 2018. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Bank of Montreal reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Bank of Montreal sold 111,750 Clovis Oncology, Inc. shares in Q4 2022, an estimated $136.
Bank of Montreal first reported a position in Clovis Oncology, Inc. in Q2 2014 and held it in 29 quarters.
Bank of Montreal's Clovis Oncology, Inc. position peaked at $1.06M in Q3 2018.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.